Notification
No new Notification messages
Hyundai Motor India IPO is Open!
Apply for the Hyundai Motor India IPO through UPI in just minutes
HCL Technologies Q2 Results FY'25
HCL Tech announced its Q2 FY'25 results, revenue jumped by 8.2% YoY at ₹28,862 crores, and Net Income stood at ₹4,235 crores up 10.5% YoY.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.

Poly Medicure Launches ₹1,000 Cr QIP, Plans for Expansion and Growth

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Synopsis:

Poly Medicure launched a ₹1,000 crore QIP with shares priced at ₹1,850-₹1,880, leading to a 5.54% equity dilution. The Poly Medicure share price closed at ₹2,120, up 8.61%, reflecting strong investor confidence despite the discount.

Poly Medicure News Today

Poly Medicure Limited, a leading medical consumables company, has launched a Qualified Institutional Placement (QIP) to raise ₹1,000 crore. The move is part of the company’s strategy to fund new manufacturing facilities, pursue inorganic growth opportunities, and address general corporate expenses.

Details of the QIP

The QIP offers shares within an indicative price range of ₹1,850 to ₹1,880 each. This pricing represents a discount of approximately 11.6% compared to Poly Medicure’s share price of ₹2,120 on August 19. The QIP is expected to result in an equity dilution of 5.54% relative to the pre-issue outstanding capital.

Use of Proceeds

The capital raised through this QIP will be primarily allocated towards capital expenditure for establishing new manufacturing units. Additionally, Poly Medicure plans to use the funds to explore inorganic growth opportunities, potentially through acquisitions or strategic partnerships, and for general corporate purposes.

Promoter Lock-Up and Management

The QIP includes a promoter lock-up period of 90 days following the closing date, which is standard in such placements to prevent any immediate sell-off by promoters. IIFL Securities Limited and SBI Capital Markets Limited have been appointed as the Book Running Lead Managers (BRLMs) for this QIP, overseeing the entire process.

Poly Medicure Share Price Performance

On the day of the QIP announcement, the Poly Medicure share price surged by ₹168.05, or 8.61%, closing at ₹2,120 on the NSE. Despite the QIP’s discount, the share price performance indicates strong investor confidence in the company’s growth prospects.

Over the past 12 months, Poly Medicure shares have delivered an impressive return of 48.37%.

Key Takeaways

Poly Medicure's ₹1,000 crore QIP is a strategic move to strengthen its manufacturing capacity and pursue growth opportunities. Despite the discount offered in the QIP, the strong upward movement in the Poly Medicure share price reflects investor optimism about the company's plans.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text